Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett esophagus.

P Sharma1, R E Sampliner

  • 1Department of Medicine, University of Kansas and Veterans Administration Medical Center, Kansas City, Missouri, USA.

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance of patients post-endovascular aneurysm repair.

Postgraduate medical journal·2007
Same author

Epidural empyema secondary to orbital cellulitis: a case report.

European journal of ophthalmology·2007
Same author

Epidemilogical analysis of Neisseria gonorrhoeae isolates by antimicrobial susceptibility testing, auxotyping and serotyping.

Indian journal of medical microbiology·2007
Same author

ParDOCK: an all atom energy based Monte Carlo docking protocol for protein-ligand complexes.

Protein and peptide letters·2007
Same author

Comparative study of misoprostol vs dinoprostone for induction of labour.

Indian journal of physiology and pharmacology·2007
Same author

Effect of therapy on serum zinc and copper in primary complex of children.

Biological trace element research·2007
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Barrett esophagus, a risk factor for esophageal adenocarcinoma, is being studied for its epidemiology, detection, and treatment. While high-dose acid suppression is disappointing, endoscopic therapies show promise.

Area of Science:

  • Gastroenterology
  • Oncology
  • Gastroesophageal Reflux Disease

Background:

  • Barrett esophagus is a condition linked to chronic gastroesophageal reflux.
  • Esophageal adenocarcinoma risk is associated with Barrett esophagus.
  • Recent research focuses on epidemiology, prevalence, detection, and treatment.

Purpose of the Study:

  • To review recent advancements in understanding Barrett esophagus.
  • To highlight key findings in epidemiology, risk factors, and therapeutic approaches.
  • To assess the current landscape of Barrett esophagus research.

Main Methods:

  • Literature review of recent publications on Barrett esophagus.
  • Analysis of epidemiological data and risk factors, including gastroesophageal reflux.

Related Experiment Videos

  • Evaluation of diagnostic biomarkers and treatment outcomes, including endoscopic therapies.

    • Main Results:

    • Chronic gastroesophageal reflux is a significant risk factor for esophageal adenocarcinoma.
    • The prevalence of short/long Barrett esophagus and cardia intestinal metaplasia has been better defined.
    • High-dose proton pump inhibition shows limited impact on Barrett esophagus surface area.
    • Biomarkers may aid in identifying high-risk individuals for neoplasia.
    • Endoscopic therapies for Barrett esophagus are promising.

    Conclusions:

    • Barrett esophagus remains an area of active investigation.
    • Effective strategies for managing Barrett esophagus and preventing esophageal adenocarcinoma are evolving.
    • Further research into biomarkers and advanced endoscopic treatments is warranted.